[1]
B. Wirk and X. Deng, “Post-Transplant Cyclophosphamide Allows Allogeneic Hematopoietic Stem-Cell Transplantation Across Donor Types for Nonmalignant Hematologic Diseases”, J Hematol, vol. 15, no. 2, pp. 71–79, Jan. 2026, doi: 10.14740/jh2184.